Brazilian Prez thanks Modi for allowing export of raw materials to produce hydroxychloroquine

Image
Press Trust of India New Delhi
Last Updated : Apr 09 2020 | 4:42 PM IST

Brazilian President Jair Bolsonaro has thanked Prime Minister Narendra Modi for facilitating export of raw materials to Brazil for production of anti-malarial drug hydroxychloroquine, seen as a possible cure for COVID-19.

In his address to the nation on Wednesday, Bolsonaro said Brazil will receive the ingredients from India for production of hydroxychloroquine on Saturday, and thanked Modi for the "timely help".

"We have more good news. As an outcome of my direct conversation with Prime Minister of India, we will receive, by Saturday, raw materials to continue our production of Hydroxychloroquine so that we can treat patients of COVID-19 as well as of lupus, malaria, and arthritis," he said.

"I thank Prime Minister Narendra Modi and the people of India for such timely help to the people of Brazil," the Brazilian leader said.

US President Donald Trump has also thanked Modi for allowing the export of the drug to the US and said India's help during the crisis will not be forgotten.

On March 25, India banned export of hydroxychloroquine in the midst of views in some quarters that the drug could be used to fight COVID-19. India is the largest exporter of the drug. The ban was partially lifted on Tuesday.

Modi and Bolsonaro had a telephonic conversation on April 4 during which the Brazilian leader requested Modi to allow export of the drug as well as raw materials for its production in Brazil.

Separately, in a letter to Modi on Tuesday, Bolsonaro mentioned that two Brazilian laboratories, EMS and Apsen, have been importing raw materials from India for several years to produce hydroxychloroquine and that Brazil's internal supply of the drug depends on its production by the two firms.

Bolsonaro requested Modi to ensure that Brazil gets supply of the raw materials ordered prior to imposition of the ban on hydroxychloroquine.

In the letter to Modi, the Brazilian leader invoked ancient Indian epic, Ramayana, mentioning the story of how Lord Hanuman brought a holy medicine from the Himalayas to save the life of Laxmana.

Brazil, the largest country in Latin America, has recorded close to 14,000 coronavirus cases and over 660 deaths in the infection. Globally, the virus has killed over 75,000 people and infected more than 13 lakh.

Bolsonaro said Brazil hopes that use of the hydroxychloroquine will help in treatment of the virus infected people in his country.

"Like many other countries, Brazil places hope in the use of hydroxychloroquine as an effective means to treat patients who have contracted COVID-19," the Brazilian leader wrote in the letter.

The Brazilian leader also referred to partnership between the two countries in the pharmaceutical sector, adding leading Brazilian pharmaceutical laboratories have a "solid and long" partnership with Indian laboratories.

Scientists and the medical fraternity are racing against time to find a vaccine and a therapeutic solution to the infection that originated in the central Chinese city of Wuhan in December.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.

India manufactures 70 per cent of the world's supply of hydroxychloroquine, according to Indian Pharmaceutical Alliance (IPA) secretary-general Sudarshan Jain.

A sizeable number of countries have requested India to supply hydroxychloroquine to fight the coronavirus pandemic.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 09 2020 | 4:42 PM IST

Next Story